Seller record · Telehealth service

DudeMeds

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The terms reach only a consent authorizing DudeMeds pharmacy partners to provide products, which identifies no facility. 2 more criteria also fail; see the table below.

At a glance

DudeMedsTelehealth service

5/8criteria passed

Price: Printed on its own pages before sign-up
Sells: semaglutide, oral and injectable, tirzepatide, oral and injectable, and 3 more
FDA letters: None on file

Partner link. The site earns a commission on care started through it. Funding

Visit DudeMeds See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A men's telehealth service selling semaglutide and tirzepatide for weight loss, prescription NAD+ for anti-aging, and testosterone therapy. It publishes a starting price for each category and never states whether the medication it ships is compounded.

Operating entity DudeMeds LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	DudeMeds' weight loss page
S2	Prescription gating	PASS	DudeMeds' patient type page
S3	Pharmacy identification	FAIL	DudeMeds' terms and conditions
S4	Compounding disclosure	FAIL	DudeMeds' weight loss page
S5	Analytical documentation	FAIL	DudeMeds' website
S6	Business address	PASS	DudeMeds' contact page
S7	Price disclosure	PASS	DudeMeds' weight loss page
S8	Enforcement status	PASS	FDA's website

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSLicensed healthcare providers review the consultation and decide whether to prescribe, stated on the weight-loss and anti-aging pages.Source: DudeMeds' weight loss page.

S2PASSA free consultation gates the order and the purchase path leads to a patient portal rather than to a cart.Source: DudeMeds' patient type page.

S3FAILNo filling pharmacy is named. The terms reach only a consent authorizing DudeMeds pharmacy partners to provide products, which identifies no facility.Source: DudeMeds' terms and conditions.

S4FAILThe compounding status of what it ships is never disclosed, and the weight-loss page calls both drugs it sells FDA-approved. It says “Semaglutide is an FDA-approved medication shown to significantly aid weight loss by reducing appetite and promoting a feeling of fullness” and “Tirzepatide is an FDA-approved medication, effectively supports weight loss by mimicking hormones that regulate appetite and blood sugar levels”, at prices from 149 dollars a month. The word compounded appears neither on that page nor anywhere in the terms.Source: DudeMeds' weight loss page.

S5FAILNo certificate, lot report or purity figure is published or linked anywhere on the site.Source: DudeMeds' website.

S6PASSThe contact page prints a street address with a unit number in Wilmington, Delaware, beside a support email address.Source: DudeMeds' contact page.

S7PASSThe weight-loss page states a starting monthly price before intake, and the anti-aging page states a monthly price for NAD+.Source: DudeMeds' weight loss page.

S8PASSNo FDA warning letter names the brand or the operating entity DudeMeds LLC, and no action has halted the business.Source: FDA's website.

Products shown on the seller's own pages at the recorded date: semaglutide, oral and injectable, tirzepatide, oral and injectable, prescription NAD+, testosterone replacement therapy, hair, skin and sexual health medications.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells NAD+

Partner link. The site earns a commission on care started through it. Funding.

Visit DudeMeds

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.